Philip G. Kasprzyk

2.2k total citations
50 papers, 1.8k citations indexed

About

Philip G. Kasprzyk is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Philip G. Kasprzyk has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 25 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Philip G. Kasprzyk's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Cancer therapeutics and mechanisms (8 papers) and HER2/EGFR in Cancer Research (8 papers). Philip G. Kasprzyk is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Cancer therapeutics and mechanisms (8 papers) and HER2/EGFR in Cancer Research (8 papers). Philip G. Kasprzyk collaborates with scholars based in United States, France and United Kingdom. Philip G. Kasprzyk's co-authors include C. Richter King, James L. Mulshine, Anthony M. Treston, Olivier Lavergne, Frank Cuttitta, Ira Pastan, Sun U. Song, Pier Paolo Di Fiore, Grégoire Prévost and Danièle Demarquay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Philip G. Kasprzyk

50 papers receiving 1.7k citations

Peers

Philip G. Kasprzyk

ONCOL

RNMI

IMMUN

Grégoire Prévost France

Jeffrey H. Till United States

Wilma M. McKoy United States

Yukimasa Shiotsu Japan

J A Double United Kingdom

Gillian Paine-Murrieta United States

Abhijit Bhat United States

Zhong-Yin Zhang United States

Ana M. Tari United States

Aruna Basu United States

Grégoire Prévost France

Philip G. Kasprzyk

1.0k ×0.9

645 ×1.0

ONCOL

138 ×0.4

RNMI

181 ×0.6

70 ×0.3

IMMUN

Citations per year, relative to Philip G. Kasprzyk Philip G. Kasprzyk (= 1×) peers Grégoire Prévost

Countries citing papers authored by Philip G. Kasprzyk

Since Specialization

Citations

This map shows the geographic impact of Philip G. Kasprzyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip G. Kasprzyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip G. Kasprzyk more than expected).

Fields of papers citing papers by Philip G. Kasprzyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip G. Kasprzyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip G. Kasprzyk. The network helps show where Philip G. Kasprzyk may publish in the future.

Co-authorship network of co-authors of Philip G. Kasprzyk

This figure shows the co-authorship network connecting the top 25 collaborators of Philip G. Kasprzyk. A scholar is included among the top collaborators of Philip G. Kasprzyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip G. Kasprzyk. Philip G. Kasprzyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kasprzyk, Philip G., Larry M. Tremaine, Odette A. Fahmi, & Jing‐Ke Weng. (2023). In Vitro Evaluation of the Potential for Drug Interactions by Salidroside. Nutrients. 15(17). 3723–3723. 4 indexed citations

Döhle, Wolfgang, Mathew P. Leese, Fabrice Jourdan, et al.. (2014). Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1‐Substituted Tetrahydroisoquinolines. ChemMedChem. 9(2). 350–370. 15 indexed citations

Brézak, Marie-Christine, Annie Valette, Muriel Quaranta, et al.. (2008). IRC‐083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells. International Journal of Cancer. 124(6). 1449–1456. 42 indexed citations

Prévost, Grégoire, Muriel Quaranta, Céline Frongia, et al.. (2007). A novel synthetic CDC25 phosphatase inhibitor inhibits human cancer growth in vitro and in vivo. Cancer Research. 67. 3228–3228. 1 indexed citations

Foster, Paul, Simon P. Newman, Philip G. Kasprzyk, et al.. (2007). 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique. Breast Cancer Research and Treatment. 111(2). 251–260. 30 indexed citations

Newman, Stephen T., Paul Foster, Joanna M. Day, et al.. (2007). The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers. British Journal of Cancer. 97(12). 1673–1682. 25 indexed citations

Prévost, Grégoire, Anne Pradines, Marie-Christine Brézak, et al.. (2001). Inhibition of human tumor cell growthin vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228. International Journal of Cancer. 91(5). 718–722. 23 indexed citations

Demarquay, Danièle, Marion Huchet, Hélène Coulomb, et al.. (2001). The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poison. Anti-Cancer Drugs. 12(1). 9–19. 24 indexed citations

Papadopoulos, Vassilios, Hua Li, Hakima Amri, et al.. (2000). Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells.. PubMed. 20(5A). 2835–47. 50 indexed citations

10.

Huchet, Marion, Danièle Demarquay, Hélène Coulomb, et al.. (2000). The Dual Topoisomerase Inhibitor, BN 80927, Is Highly Potent against Cell Proliferation and Tumor Growth. Annals of the New York Academy of Sciences. 922(1). 303–305. 13 indexed citations

11.

Lavergne, Olivier, Danièle Demarquay, Philip G. Kasprzyk, & Dennis Bigg. (2000). Homocamptothecins: E‐Ring Modified CPT Analogues. Annals of the New York Academy of Sciences. 922(1). 100–111. 20 indexed citations

12.

King, C. Richter, Philip G. Kasprzyk, Paul H. Fischer, Robert E. Bird, & Nancy A. Turner. (1996). Preclinical testing of an anti-erbB-2 recombinant toxin. Breast Cancer Research and Treatment. 38(1). 19–25. 9 indexed citations

13.

Reiter, Yoram, Ulrich Brinkmann, B. Lee, et al.. (1994). Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment. Journal of Biological Chemistry. 269(28). 18327–18331. 81 indexed citations

14.

Avis, Ingalill, Frank Cuttitta, Anthony M. Treston, et al.. (1993). Effect of gastrin‐releasing peptide on the pancreatic tumor cell line (capan). Molecular Carcinogenesis. 8(4). 214–220. 16 indexed citations

15.

Kasprzyk, Philip G., Sun U. Song, Pier Paolo Di Fiore, & C. Richter King. (1992). Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies.. PubMed. 52(10). 2771–6. 135 indexed citations

16.

Kovacs, T. O. G., Philip G. Kasprzyk, Anthony M. Treston, et al.. (1991). Preclinical Evaluation of an Anti-Autocrine Growth Factor Monoclonal Antibody for Treatment of Patients With Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 83(20). 1470–1476. 30 indexed citations

17.

Mulshine, James L., Anthony M. Treston, Ronald B. Natale, et al.. (1989). Autocrine Growth Factors as Therapeutic Targets in Lung Cancer. CHEST Journal. 96(1). 31S–34S. 6 indexed citations

18.

Kasprzyk, Philip G., Ingalill Avis, Yoichi Nakanishi, et al.. (1988). Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation. Analytical Biochemistry. 174(1). 224–234. 11 indexed citations

19.

Nakanishi, Yoichi, et al.. (1988). Growth Factor Effects on Small Cell Lung Cancer Cells Using a Colorimetric Assay: Can a Transferrin-Like Factor Mediate Autocrine Growth?. Pathobiology. 56(1-2). 74–85. 21 indexed citations

20.

Kasprzyk, Philip G., Frank Cuttitta, Anthony M. Treston, et al.. (1988). Consideration of the Chemistry of Solid‐Phase Matrix Interactions Leads to Improved Quantitation of Neuropeptides^a,^b. Annals of the New York Academy of Sciences. 547(1). 41–53. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact